Brainlab Ag News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abbott Laboratories received U.S. FDA clearance for its Liberta RC deep brain stimulation (DBS) system for use in movement disorders, less than two weeks after the agency gave its nod to Medtronic’s Percept RC DBS system. The news come on the heels of Abbott’s release of strong fourth quarter results on Wednesday.

Neuronavigation Systems Market size to grow by USD 227.65 million from 2023-2028 | Apollo Hospitals Enterprise Ltd., B.Braun SE, Brainlab AG, and more among the key companies in the market - Technavio